氨甲环酸不能显著减少内镜鼻窦与鼻腔手术后的术后出血
这项随机双盲安慰剂对照试验于2021年4月至11月开展,将接受内镜鼻窦或鼻腔手术的患者随机分为两组,在拔管前分别静脉给予1 g氨甲环酸或生理盐水。共40例患者完成研究,结果显示氨甲环酸组与生理盐水组在手术当天的术后出血视觉模拟评分(VAS)无显著差异,术后7天内各时间点及额外干预需求也均无显著差异。
要点
- 氨甲环酸组手术当天出血VAS为4.82±2.18英寸,生理盐水组为5.03±2.14英寸,p=0.8,无显著差异。
- 术后第7天两组VAS分别为0.67±1.84英寸与0.87±0.99英寸,p=0.7,无显著差异。
- 两组在额外评估、填塞或返回手术室等干预需求上无显著差异。
核心结论
- 尽管氨甲环酸既往被证明可减少鼻窦手术中的术中出血,但当术后出血基线水平已较低时,氨甲环酸似乎不能进一步显著减少术后出血。
研究设计与样本
- 随机双盲安慰剂对照试验,于2021年4月至11月开展,共40例患者完成研究。
- 患者拟接受内镜鼻窦或鼻腔手术,随机分为两组,在术中拔管前分别静脉给予1 g氨甲环酸或生理盐水。
主要发现
- 氨甲环酸组手术当天术后出血VAS为4.82±2.18英寸,生理盐水组为5.03±2.14英寸,p=0.8,无显著差异。
- 术后第7天氨甲环酸组VAS为0.67±1.84英寸,生理盐水组为0.87±0.99英寸,p=0.7,无显著差异。
- 术后7天内任何一天两组间均无显著差异,与各自手术当天基线相比的VAS下降幅度也无显著差异。
- 两组在额外干预(如恢复室、急诊或门诊的额外评估,填塞需求,或返回手术室)方面无显著差异。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative epistaxis is a known possibility following endoscopic sinonasal surgery. Tranexamic acid (TXA) has been shown to reduce intraoperative blood loss and improve the visual field. This study evaluated the clinical efficacy of TXA when given at end of surgery to reduce postoperative bleeding. METHODS: This randomized, double-blinded placebo-controlled trial was conducted from April to November 2021. Patients scheduled to undergo endoscopic sinus or nasal surgery were randomized to receive an intravenous dose of 1 g TXA or saline intraoperatively prior to extubation. A 10-in. visual analog scale (VAS) was used to query patients regarding postoperative bleeding each day for 1 week. The medical record was examined to determine the need for additional evaluations or interventions for epistaxis. RESULTS: Forty patients completed the study. The mean ± SD postoperative bleeding VAS for the TXA group on the day of surgery was not significantly different from the saline group (4.82 ± 2.18 in. vs. 5.03 ± 2.14 in., p = 0.8). There were no significant differences between treatment arms on any postoperative day through day 7 (0.67 ± 1.84 in. vs. 0.87 ± 0.99 in., p = 0.7), nor in the reduction in VAS compared to the respective baseline on the day of surgery. There were no significant differences in terms of additional interventions (e.g., additional evaluation in recovery, ED, or clinic, need for packing, or return to the operating room [OR]). CONCLUSION: Although TXA has previously demonstrated efficacy to reduce intraoperative bleeding during sinonasal surgery, when postoperative bleeding is already minimal at baseline, TXA does not appear to reduce it significantly further.
引用
- Khanwalkar A, Chan E, Roozdar P, et al. Tranexamic acid does not significantly lower postoperative bleeding after endoscopic sinus and nasal surgery. Int Forum Allergy Rhinol. 2023. PMID: 36608352. doi:10.1002/alr.23127
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。